FENTANYL-HAMELN (Hameln Pharma Pty Ltd)
Product name
FENTANYL-HAMELN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
123 (255 working days)
Active ingredients
fentanyl
Registration type
New generic medicine
Indication
Fentanyl-hameln is indicated for:
- analgesic action of short duration during anaesthetic periods, premedication, induction and maintenance, and in the immediate post-operative period (recovery room) as the need arises;
- use as an opioid analgesic supplement in general and regional anaesthesia;
- administration with a neuroleptic such as droperidol injection as an anaesthetic premedication, for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.